Essentially, doctors harvest stem cells from a patient’s healthy eye, grow them in a lab over several weeks, and then transplant them into the damaged eye. Once in place, these stem cells help ...

The data were presented today at the 77th Annual Wills Eye Conference in Philadelphia, Pennsylvania. Findings from six patients in the first low-dose cohort of the ongoing first-in-human trial ...

In a desirable "side effect," the new technology creates a dense and accurate surface reconstruction of the eye, which could potentially be used for on-the-fly diagnosis and correction of specific ...

Dr. Hanneken, who is a pioneer in donor human eye revival, and Professor Dayeh, who will serve as the neuromodulation architect on the project, will jointly work with Dr. Jeffrey Goldberg, Blumenkranz ...